Global Regulatory & Evidence Group Expertise

Regulatory Strategy

Navigate complexity with a strategy built for what comes next.

What we solve

Regulatory complexity rarely begins with a regulatory question.

A development decision can affect the evidence package. An evidence gap can change an agency interaction. A market-specific requirement can reshape a global strategy. GR&EG helps clients understand those connections early—before they become submission risks, timeline pressures, or costly changes in direction.

Uncertain pathways

Clarify regulatory options, requirements, risks, and decision points.

Evidence gaps

Identify where the existing evidence package may not fully support regulatory objectives.

Cross-market complexity

Build a coherent global strategy while accounting for meaningful local differences.

Common client questions

Questions we help clients answer

Is our current evidence package sufficient for the regulatory objective we're pursuing?
What should we ask and what do we need to know before our next agency interaction?
Where are the regulatory vulnerabilities in our development or submission strategy?
How will new clinical or real-world evidence change our regulatory approach?
Can one global development strategy support the needs of our priority markets?
What decisions do we need to make now to avoid limiting our options later?
Capabilities

How we help

Regulatory strategy & pathway assessment

Evaluate potential pathways and define a practical route from development through approval.

Agency interaction planning

Shape objectives, questions, briefing strategy, and preparation for productive health-authority engagement.

Submission strategy

Connect evidence, messaging, documentation, and timing into a coherent submission plan.

Regulatory intelligence

Translate evolving guidance, precedent, and agency expectations into implications for the program.

Lifecycle management

Support indication expansion, labeling evolution, post-approval commitments, and changing evidence needs.

Global regulatory alignment

Maintain a consistent scientific strategy while anticipating market-specific requirements and expectations.

How GR&EG approaches it

Clarity before complexity.

We begin with the decision that needs to be made, then work backward to understand the regulatory environment, available evidence, stakeholder expectations, and consequences of each path forward.

01 — DEFINE

Clarify

Define the decision, objective, constraints, and critical uncertainties.

02 — ASSESS

Evaluate

Assess the evidence, regulatory landscape, precedent, and stakeholder expectations.

03 — STRATEGIZE

Choose

Identify viable paths, tradeoffs, risks, and the evidence or engagement needed to move forward.

04 — EXECUTE

Act

Translate strategy into agency interactions, submissions, evidence plans, and actionable decisions.

Related expertise

Regulatory decisions don't happen in isolation.

Regulatory Insight

The Evolving Global Regulatory Landscape

How shifting agency expectations are changing evidence and submission strategy.

Read insight
Start a conversation

Facing a regulatory decision with no obvious answer?

Bring us the question. We'll help clarify the evidence, risks, options, and path forward.

Discuss Your Needs →